clinical – ENOVAT

Driving laboratory standardisation of bacterial culture and antimicrobial susceptibility testing in veterinary clinical microbiology in Europe and beyond

Enovat publications
antimicrobials, bacteria, clinical, diagnostics, europe, microbiology, veterinary
February 20, 2021

Dorina Timofte, et al. on behalf of ENOVAT, ESGVM, ECVM and EAVLD. Journal of Clinical Microbiology Dec 2020, JCM.02572-20; DOI: 10.1128/JCM.02572-20

View Post

COST

COST (European Cooperation in Science and Technology) is a funding agency for research and innovation networks. Our Actions help connect research initiatives across Europe and enable scientists to grow their ideas by sharing them with their peers. This boosts their research, career and innovation.

COST Action CA18217

The COST Action CA18217 European Network for Optimization of Veterinary Antimicrobial Treatment (ENOVAT) aims to optimize veterinary antimicrobial use with special emphasis on the development of animal- and disease-specific antimicrobial treatment guidelines and refinement of microbiological diagnostic procedures.

Action Details

MoU 034/19: Memorandum of Understanding
CSO Approval date: 04/06/2019
Action duration: 15/11/2019 – 14/11/2023
Participations: More than 250 participants from 45 countries
Email contact: info@enovat.eu

Driving laboratory standardisation of bacterial culture and antimicrobial susceptibility testing in veterinary clinical microbiology in Europe and beyond

Tag Cloud